[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"food-selection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:food-selection":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,42,68,88,129,151,177,207],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100590609","influence-of-likes-in-social-media-food-ads-on-black-and-white-adolescents-food-purchases---study-2-100590609",false,"NCT06969638","Influence of \"Likes\" in Social Media Food Ads on Black and White Adolescents' Food Purchases - Study 2","A Randomized Trial to Examine the Influence of \"Likes\" in Social Media Food Ads on Black and White Adolescents' Food Purchases - Study 2","Inclusion Criteria:\n\n* adolescent (13-17 years of age) who identifies as only non-Latino White or only Black\u002FAfrican American; who logs into Instagram once daily; who can read and speak English\n\nExclusion Criteria:\n\n\\- participants who do not meet all criteria described above.",true,"ALL","13 Years","17 Years",{"count":21,"type":22},1300,"ESTIMATED","INTERVENTIONAL",[25],"NA","This is a randomized trial to examine the influence of number of \"likes\"on social media food ads on Black and White adolescents' food purchases",[28],"Food Selection","RECRUITING","2026-06-08",{"date":32,"type":33},"2026-06-10","ACTUAL",{"date":35,"type":33},"2025-04-29",{"date":37,"type":22},"2027-06",{"name":39,"class":40},"NYU Langone Health","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":16,"sex":17,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":23,"phases":53,"briefSummary":54,"conditions":55,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":41},"100507005","integrating-food-rx-with-best-feeding-practices-with-efnep-100507005","NCT05881759","Integrating Food Rx With Best Feeding Practices With EFNEP","Integrating Food Rx With Best Feeding Practices for Chronic Disease Prevention Among EFNEP Participants","Inclusion Criteria:\n\n* Living in Harris or Fort Bend counties\n* being a parent of a child 4-8 years old\n* ability to speak in English or Spanish\n* have ready access to a telephone\n* have access to the Internet with a smart phone, a tablet, a laptop, or a desktop computer\n\nExclusion Criteria:\n\n* parents of children with disabilities and\u002For those on prescription medications that affect weight and\u002For appetite\n* parents who are not able to complete self-report questionnaires","18 Years","64 Years",{"count":52,"type":22},375,[25],"To assess feasibility and acceptability of of integrating Food Rx and Best Feeding Practices with EFNEP participants via a pilot study.",[56,57,28,58],"Dietary Habits","Childhood Obesity","Feeding Behavior","2026-06-01",{"date":61,"type":33},"2026-06-02",{"date":63,"type":33},"2024-01-15",{"date":65,"type":22},"2027-03-31",{"name":67,"class":40},"Baylor College of Medicine",{"id":69,"slug":70,"hasResults":11,"nctId":71,"briefTitle":72,"officialTitle":72,"acronym":4,"eligibilityCriteria":73,"healthyVolunteers":16,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":74,"targetDuration":4,"studyType":23,"phases":76,"briefSummary":77,"conditions":78,"keywords":4,"overallStatus":80,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":85,"leadSponsor":86,"locationsCount":41},"100639758","using-single-and-combined-nudge-strategies-to-promote-healthier-beverage-intake-among-college-students-100639758","NCT07625969","Using Single and Combined Nudge Strategies to Promote Healthier Beverage Intake Among College Students","Inclusion Criteria:\n\n* college students\n* willing to participate\n\nExclusion Criteria:\n\nnone",{"count":75,"type":22},1000,[25],"The primary objective of this study was to examine whether three nudging strategies influence beverage consumption behavior among Chinese university students. These interventions included health warning messages, hedonic labeling, and a combination of health warning and hedonic labeling. A between-subjects experimental design with a single factor was employed to assess the effects of these strategies on students' choices between sugar-sweetened and sugar-free beverages, thereby evaluating their effectiveness in promoting healthier beverage selections.",[79,28],"Obesity","NOT_YET_RECRUITING","2026-05-29",{"date":83,"type":33},"2026-06-04",{"date":81,"type":22},{"date":32,"type":22},{"name":87,"class":40},"Nanjing Medical University",{"id":89,"slug":90,"hasResults":11,"nctId":91,"briefTitle":92,"officialTitle":93,"acronym":4,"eligibilityCriteria":94,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":95,"enrollmentInfo":96,"targetDuration":4,"studyType":23,"phases":98,"briefSummary":99,"conditions":100,"keywords":114,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":123,"completionDateStruct":125,"leadSponsor":127,"locationsCount":41},"100596191","the-florida-ascent-study-100596191","NCT07042243","The Florida ASCENT Study","The Florida Partnership for Adding Social Context to Address Cancer Survivorship Outcomes (Florida ASCENT)","Patient Eligibility Inclusion Criteria:\n\n1. ≥18 years old.\n2. Pathologically confirmed diagnosis of colorectal, prostate, lung, breast, gynecologic, hematologic, or skin (including melanoma) cancer within the past 12 months.\n3. Self-reported ability to read and speak English.\n4. Able to provide informed consent.\n5. Participant must not be considered a \"vulnerable population\" (pregnant women, neonates, children etc.)\n\nPatient Eligibility Exclusion Criteria:\n\n1. ≤18 years old.\n2. Participant do not have a pathologically confirmed diagnosis of colorectal, prostate, lung, breast, gynecologic, hematologic, or skin (including melanoma) cancer within the past 12 months.\n3. Participant does not live within the state of Florida.\n\n3\\) Does not self-reported ability to read and speak English or Spanish. 4) Not able to provide informed consent. 5) Participant is considered a \"vulnerable population\" (pregnant women, neonates, children etc.)\n\nProvider Eligibility Inclusion Criteria\n\n1. ≥18 years old.\n2. Currently works as a physician, physician assistant, patient navigator and\u002For health system\u002Fadministrative leader in UF and UM affiliated clinics.\n3. Self-reported ability to read and speak English or Spanish.\n4. Able to provide informed consent.\n5. Participant must not be considered a \"vulnerable population\" (pregnant women, neonates, children etc.)\n\nProvider Eligibility Exclusion Criteria\n\n1. ≤ 18 years old.\n2. Does not currently works as a physician, physician assistant, patient navigator and\u002For health system\u002Fadministrative leader in UF and UM affiliated clinics.\n3. Does not self-report having the ability to read and speak English.\n4. Not able to provide informed consent.\n5. Participant is considered a \"vulnerable population\" (pregnant women, neonates, children etc.)","100 Years",{"count":97,"type":22},100,[25],"The goal of this clinical trial is to adapt, implement, and evaluate MyCarePulse and ASCENT patient navigator to overcome barriers to care among patients with cancer.\n\nThe main hypotheses it aims to test are:\n\n* At the patient level, the intervention will result in higher levels of food security, self- efficacy for dietary behaviors, and higher diet quality than standard care.\n* At the provider level, the intervention will be feasible, acceptable, appropriate, and able to enhance individualized care for patient wellness.\n\nResearchers will compare cancer patients receiving the MyCarePulse and ASCENT patient navigator intervention to those receiving standard care, to see if the intervention improves food security, self-efficacy, and diet quality.\n\nPhase 1\n\nPatient Participants will:\n\n* Complete the ASCENT Questionnaire, which is comprised of the following:\n\n  * U.S. Food Security Survey Module (U.S. FSSM)\n  * Patient-Reported Outcomes Measurement Information System (PROMIS-29)\n  * Automated Self-Administered 24-Hour (ASA24®) Dietary Assessment Tool\n* Be assessed using the Veggie Meter instrument\n* Participate in two semi-structured interviews\n\nProvider Participants will:\n\n•Participate in one semi-structured interview\n\nPhase 2\n\nPatient Participants will:\n\n* Participate in ASCENT patient navigator screenings and consultations\n* Complete the ASCENT Questionnaire, which comprises the U.S. FSSM, PROMIS-29, and ASA24®",[101,102,103,28,104,105,106,107,108,109,110,111,112,113],"Cancer","Food Deprivation","Food Habits","Colorectal Cancer","Prostate Cancer","Lung Cancer","Breast Cancer","Gynecologic Cancer","Hematologic Cancer","Skin Cancer","Melanoma","Nutrition Poor","Nutritional Deficiency",[115,101,116,117,118,119],"Food Insecurity","Food Access","Community-Informed Research","Nutritional Needs","Mixed-Methods","2026-02-19",{"date":122,"type":33},"2026-02-20",{"date":124,"type":33},"2025-12-05",{"date":126,"type":22},"2027-08",{"name":128,"class":40},"University of Florida",{"id":130,"slug":131,"hasResults":11,"nctId":132,"briefTitle":133,"officialTitle":134,"acronym":4,"eligibilityCriteria":135,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":136,"targetDuration":4,"studyType":23,"phases":138,"briefSummary":139,"conditions":140,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":143,"lastUpdatePostDateStruct":144,"startDateStruct":146,"completionDateStruct":148,"leadSponsor":150,"locationsCount":41},"100612116","influence-of-social-media-ads-on-food-choice---master-protocol-100612116","NCT07249398","Influence of Social Media Ads on Food Choice - Master Protocol","Examining Influence of Social Media Ads on Black and White Adolescents' Food Choices: Master ClinicalTrials.Gov Protocol for Aim 1 (NCT05380505), Aim 2 (NCT06969638) and Aim 3 (NCT06969651).","Inclusion Criteria:\n\n1. be 13-17 years of age;\n2. identify as only non-Latino White or only Black\u002FAfrican American;\n3. report that they log into Facebook at least once daily; and\n4. read and speak English.\n\nExclusion Criteria:\n\n* Any criteria not met as listed above will bar an adolescent from participating in the study.",{"count":137,"type":22},3650,[25],"This is a Master ClinicalTrials.gov Protocol for study 20-01796:\n\nAim 1: Examining Influence of Social Media Ads on Black and White Adolescents' Food Choices - Study 1 (NCT05380505)\n\nAim 2: A Randomized Trial to Examine the Influence of \"Likes\" in Social Media Food Ads on Black and White Adolescents' Food Purchases - Study 2 (NCT06969638)\n\nAim 3: Comparing the Effects of Racial Congruence, \"Likes,\" and Food Images in Social Media Ads on Adolescents' Caloric Intake - Study 3 (NCT06969651)",[28,141,142],"Food Choices","Calorie Consumption","2025-11-18",{"date":145,"type":33},"2025-11-25",{"date":147,"type":33},"2022-03-16",{"date":149,"type":22},"2026-06",{"name":39,"class":40},{"id":152,"slug":153,"hasResults":11,"nctId":154,"briefTitle":155,"officialTitle":156,"acronym":4,"eligibilityCriteria":157,"healthyVolunteers":11,"sex":17,"minAge":49,"maxAge":4,"enrollmentInfo":158,"targetDuration":4,"studyType":160,"phases":4,"briefSummary":161,"conditions":162,"keywords":164,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":168,"lastUpdatePostDateStruct":169,"startDateStruct":171,"completionDateStruct":173,"leadSponsor":175,"locationsCount":41},"100580915","identifying-changes-in-food-behaviors-associated-with-beginning-glp-1-medication-100580915","NCT06843512","Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication","Exploring the Influence of GLP-1 Medication on Food Attitudes and Selection in a Virtual Reality Buffet","Inclusion Criteria:\n\n* Adults (18+) with overweight or obesity (BMI \\>25 kg\u002Fm2)\n* Not currently taking an incretin-based medication at baseline\n* Recently (within two weeks) prescribed a GLP-1, can be included if they have a obesity-related co-occurring condition (diabetes, hypertension, cardiovascular disease, dyslipidemia)\n* Have had no prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.\n* Fluent in English\n\nExclusion Criteria:\n\n* Adults (18+) without overweight or obesity\n* \\\u003C18 years of age at time of testing\n* Adults not taking a GLP-1 Medication\n* Adults taking a compound GLP-1\n* Adults on GLP-1 medication for longer than 2 weeks at baseline\n* Have had a prior diagnosis of cognitive or physical disability, dyslexia, or epilepsy.\n* Not fluent in English",{"count":159,"type":22},25,"OBSERVATIONAL","In recent years, GLP-1 medications have become a widely employed approach by physicians to address weight concerns in patients and lead to weight loss. Little is known, however, about how these medications may alter an individual's attitude towards food, food reactivity, or the specific types and amounts of foods an individual will choose. The purpose of this study is to observe the changes an individual experiences in their relationship and reaction to food and in their food selection prior to or within the first two weeks of taking GLP-1 medication to after three months on the medication. The researchers of this study believe that an understanding of such changes can inform questions seeking to ensure maintenance of appropriate nutrient balance within individuals on weight loss medications.",[163,28],"Weight Loss",[165,163,166,167],"GLP-1","Virtual Reality","Food behavior","2025-09-03",{"date":170,"type":33},"2025-09-10",{"date":172,"type":33},"2025-07-15",{"date":174,"type":22},"2026-12",{"name":176,"class":40},"Penn State University",{"id":178,"slug":179,"hasResults":11,"nctId":180,"briefTitle":181,"officialTitle":182,"acronym":4,"eligibilityCriteria":183,"healthyVolunteers":16,"sex":17,"minAge":184,"maxAge":185,"enrollmentInfo":186,"targetDuration":4,"studyType":23,"phases":188,"briefSummary":189,"conditions":190,"keywords":194,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":199,"lastUpdatePostDateStruct":200,"startDateStruct":202,"completionDateStruct":204,"leadSponsor":206,"locationsCount":41},"100514350","increasing-food-literacy-in-preschoolers-to-reduce-obesity-risk-100514350","NCT05977348","Increasing Food Literacy in Preschoolers to Reduce Obesity Risk","Increasing Food Literacy as a Means of Increasing Preschool Children's Food Acceptance and Reducing Obesity Risk","Inclusion Criteria:\n\n* Preschool children enrolled in participating centers\n\nExclusion Criteria:\n\n* Severe food allergies that prevent children from consuming project foods\n* Presence of a developmental or sensory disability that affects food intake and\u002For learning\n* Lack of English fluency (children and caregivers)\n* Children not regularly present during days\u002Ftimes that intervention lessons are delivered\n* Parents who are not involved in feeding\u002Fpreparing meals for children at least 50% of the time","3 Years","6 Years",{"count":187,"type":22},770,[25],"The goal of this clinical trial is to examine the effects of a nutrition education program on preschool children's food literacy and food acceptance, and to examine the added influence of a healthy eating curriculum and parent education on children's food knowledge and healthful food choices. The project will be evaluated with 450 children ages 3 to 5 years in center-based childcare programs serving predominantly Supplemental Nutrition Assistance Program (SNAP)-eligible families in Pennsylvania. Outcomes for children who receive the added healthy eating curriculum will be compared to children in classrooms that only receive the nutrition education program.",[191,28,192,193],"Food Preferences","Eating, Healthy","Obesity, Childhood",[195,196,197,198],"Food literacy","Healthy growth","Child Development","Food Acceptance","2025-03-12",{"date":201,"type":33},"2025-03-17",{"date":203,"type":33},"2023-10-03",{"date":205,"type":22},"2026-08",{"name":176,"class":40},{"id":208,"slug":209,"hasResults":11,"nctId":210,"briefTitle":211,"officialTitle":212,"acronym":213,"eligibilityCriteria":214,"healthyVolunteers":16,"sex":17,"minAge":49,"maxAge":215,"enrollmentInfo":216,"targetDuration":4,"studyType":23,"phases":218,"briefSummary":219,"conditions":220,"keywords":224,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":232,"lastUpdatePostDateStruct":233,"startDateStruct":235,"completionDateStruct":237,"leadSponsor":239,"locationsCount":41},"100498851","sleep-and-metabolism-100498851","NCT05775627","Sleep and Metabolism","Uncovering Sleep and Circadian Mechanisms Contributing to Adverse Metabolic Health","SAM","Inclusion Criteria:\n\n* Between 18 and 40 years of age\n* Drug free\n* Established disease-free status\n\nExclusion Criteria:\n\n1. Dietary restrictions\n\n   Participants must not have dietary restrictions that could systematically bias their macronutrient intake. The following will exclude participants from enrolling in the study based on their diet:\n   * Participants who choose not to or cannot consume dairy products (milk, yogurt, cheese, ice cream)\n2. Body Composition\n\n   A body mass index (BMI) of 18.5\\\u003C \\[BMI\\] \\\u003C 25 kg\u002Fm2 and a waist circumference \\\u003C94\u002F80cm.\n3. Psychiatric\u002Fpsychological suitability\n\n   Each participant will undergo a structured interview (Mini International Neuropsychiatric Interview) with a qualified OHSU physician. This physician will supervise the administration and scoring of a Beck Depression Inventory II (BDI-II) questionnaire for each potential participant. The following will exclude individuals from participating based on their psychiatric or psychological evaluation:\n   * Individuals with evidence of psychopathology on the BDI-II, or in a structured clinical interview with the physician\n   * A history of severe psychiatric illnesses\n   * Alcoholism\n   * Drug dependency\n   * Major depression\n   * Manic depressive illness\n   * Schizophrenic disorders\n   * Panic disorder\n   * Generalized anxiety disorder\n   * Post-traumatic stress disorder\n   * Agoraphobia\n   * Claustrophobia\n   * Paranoid personality disorder\n   * Schizoid personality disorder\n   * Schizotypal personality disorder\n   * Borderline personality disorder\n   * Antisocial personality disorder.\n   * History of using antidepressant medication\n   * History of using neuroleptic medication\n   * History of using tranquilizers\n4. Drug\u002Falcohol use\n\n   Volunteers must be drug-free (including caffeine, nicotine, alcohol and herbal medications) for the entire duration of the outpatient and in-laboratory study period, with no history of drug or alcohol dependency. All participants must be:\n   * Current non-smokers, and are required to have a history of less than 5 'pack years' of smoking\n5. Medication\u002Fdrug use\n\n   Volunteers must not be taking any prescribed medications or over the counter medications, with an exception for birth control.\n6. Prior shift work\n\n   For stability of endogenous circadian rhythmicity, volunteers must have no history of the following 1 year prior to the study:\n   * Working irregular day and night hours\n   * Regular night work\n   * Rotating shift work f\n   * Not have traveled more than 1 time zone during 3 months prior to the study\n7. Chronobiologic and sleep disorders\n\n   * Hypernychthemeral sleep\u002Fwake cycle\n   * Delayed sleep phase syndrome (wake time \\> 2 hours later than desired or habitually after 10:00 AM)\n   * Advanced sleep phase syndrome (wake time \\> 2 h earlier than desired or habitually before 5:00 AM)\n   * Narcolepsy\n   * Sleep apnea (apnea index \\>15)\n   * Insomnia (sleep complaint by history or polygraphically recorded sleep efficiency \\\u003C 80%)\n   * Hypersomnia\n   * Periodic Limb Movement (PLMS) (PLMS index \\>15)\n   * Nocturnal Paroxysmal Dystonia\n   * REM-sleep behavior disorder\n   * Nocturnal Enuresis; (self-report and first night in the laboratory)\n   * Obstructive sleep apnea (apnea\u002Fhypopnea index \\>5\u002Fh as determined by at-home monitoring)\n   * The investigators will also exclude individuals with extreme chronotype using the Horne-Ostberg Morningness\u002FEveningness questionnaire (i.e., the Owl\u002FLark Questionnaire)\n8. Diseases of the Cardiovascular System\n\n   * Hypertension (systolic blood pressure \\> 140 or diastolic blood pressure \\> 90)\n   * Heart failure\n   * Cardiomyopathy\n   * Cor pulmonale\n   * Ischemic heart disease\n   * Valvular heart disease\n   * History of heart transplantation\n   * Cardiac tumors\n   * Pericardial disease\n9. Metabolic Syndrome\n\n   Following American Heart Association cutoffs, participants who have, in addition to abdominal fat (obese exclusion criteria), two or more of these factors will be excluded from the study:\n   * HDL cholesterol of less than 40 mg\u002FdL in men or less than 50 mg\u002FdL in women\n   * Systolic blood pressure \\>135 mmHg or diastolic blood pressure \\>85 mmHg\n   * Fasting blood glucose ≥ 100 mg\u002FdL\n   * Triglycerides ≥ 150 mg\u002FdL\n10. Pre-Diabetes\u002FDiabetes\n\n    For participants who have a fasting blood glucose level of ≥ 100 mg\u002FdL the investigators will measure hemoglobin A1c to exclude for diabetes (HbA1c\\>5.7%).\n11. Hypertension\n\n    An upper cut off of 140\u002F90 mmHg during an office blood pressure measure will be used as an exclusion criterion. After 5 minutes of rest in a seated position, blood pressure will be measured 3 times, taken 1 minute apart. The average will be used to confirm eligibility criteria. Current or history of beta blocker use will also be exclusionary.\n12. Disorders of the Respiratory System\n\n    * Asthma\n    * Cystic fibroses\n    * Chronic bronchitis\n    * Emphysema\n    * Airway obstruction\n    * Interstitial lung diseases\n    * Pulmonary hypertension\n    * Lung neoplasms\n    * ARDS\n13. Disorders of the Kidney and Urinary Tract\n\n    * Acute or chronic renal failure\n    * History of renal transplantation\n    * Tubulointerstitial diseases of the kidney\n    * Urinary tract obstruction\n    * Tumors of the urinary tract\n14. Infectious Diseases\n\n    * Infective endocarditis\n    * HIV infection\n    * Sexually transmitted diseases \\[e.g., syphilis (including congenital syphilis and its sequelae), gonorrhea\\],\n    * Urinary tract infection\n    * Osteomyelitis\n    * Brucellosis\n    * Toxoplasmosis,\n    * Tuberculosis\n    * Leptospirosis\n    * Lyme disease\n    * Mononucleosis\n    * Hepatitis\n    * Parasitic infections such as malaria, toxoplasmosis, giardiasis, schistosomiasis, leishmaniasis\n15. Disorders of the Gastrointestinal System\n\n    * Esophagitis\n    * Peptic ulcer and gastritis\n    * Neoplasms of the esophagus, stomach or bowel\n    * Disorders of absorption\n    * Inflammatory bowel disease\n    * Diseases of the small and large intestine\n    * Acute appendicitis\n    * Cirrhosis or neoplasms of the liver\n    * History of liver transplantation\n    * Diseases of the gallbladder and bile ducts\n    * Pancreatic disease\n16. Disorders of the Immune System, Connective Tissue and Joints\n\n    * AIDS\n    * Systemic lupus erythematosus\n    * Rheumatoid arthritis\n    * Scleroderma\n    * Ankylosing spondylitis\n    * Vasculitis\n    * Sarcoidosis\n17. Disorders of the Hematopoietic System\n\n    * Anemia\n    * Leukemia\n    * Myeloproliferative diseases\n    * History of bone marrow transplantation\n18. Neoplastic Diseases\n\n    * Lymphoma\n    * Carcinoma\n    * Melanoma\n    * Any other neoplastic diseases\n19. Endocrine and Metabolic Diseases\n\n    * Thyroid disease\n    * Addison's Disease\n    * Cushing's Syndrome\n    * Aldosteronism\n    * Hypoaldosteronism\n    * Pheochromocytoma\n    * Disorders of sexual differentiation that require hormone supplementation that may alter body weight\n    * Disorders of neuroendocrine regulation\n    * Diseases of the anterior pituitary and hypothalamus\n    * Hemochromatosis porphyria\n    * Wilson's Disease\n    * Glycogen storage diseases\n    * Diseases of the parathyroid gland\n    * Metabolic bone disease\n    * Disorders of phosphorus or magnesium metabolism\n    * Paget's Disease\n20. Neurologic Disorders\n\n    * Epilepsy and disorders of consciousness\n    * Dementia\n    * Amnesic disorders\n    * Neoplastic diseases of the central nervous system\n    * Demyelinating diseases\n    * Parkinson's Disease\n    * Muscular dystrophy\n    * Myasthenia gravis\n    * Periodic paralysis\n    * Dermatomyositis\n    * Polymyositis\n    * Infections of the nervous system\n    * Stroke\n    * History of transient ischemic attacks\n    * Hydrocephalus\n    * Tumors of the pituitary gland\n    * Pinealoma\n    * Intervertebral disc disease\n    * Ataxia\n    * Gilles de la Tourette Syndrome\n    * Huntington's Disease\n    * Tardive dyskinesia\n    * History of recurrent migraine headaches\n    * Neuromuscular disease.\n21. Subjects must not be currently participating in another research study that would influence their safe participation in our study. Subjects must not be participating in a research study in which they do the following:\n\n    * Ingest experimental medication\n    * Give blood samples","40 Years",{"count":217,"type":22},20,[25],"The goal of this study is to uncover sleep and circadian mechanisms contributing to adverse metabolic health. The protocol is a 21 day (7 outpatient days, 14 inpatient days) mechanistic randomized-crossover study designed to identify the impact of chronic sleep restriction and circadian timing, independently and in combination on energy metabolism and identify the independent and combined effects on glucose tolerance.",[221,79,222,223,28],"Sleep Deprivation","Glucose Intolerance","Weight Gain",[225,226,227,228,229,230,231],"sleep restriction","obesity","glucose intolerance","weight gain","circadian timing","ad libitum","food selection","2024-04-02",{"date":234,"type":33},"2024-04-03",{"date":236,"type":33},"2023-12-01",{"date":238,"type":22},"2027-06-30",{"name":240,"class":40},"Oregon Health and Science University"]